About Event
Welcome to the 10th CDD for Biologics Summit 2025
Welcome to the 10th CDD for Biologics Summit, your one-stop shop for cutting-edge case studies and strategic insights uniting protein design, computational, machine learning, in silico, and data science experts to advance CDD for biologics. This event brings together 50+ industry pioneers across pharma and biotech companies, including GlaxoSmithKline, AstraZeneca, Amgen, AbbVie, Lilly, Novartis, and more to benchmark computational models, empower novel target discovery and advance biologics discovery.
OFFICIAL BROCHURE AVAILABLE NOW
Brand New Companies for 2025
Key Highlights
Build purposeful datasets to reduce model bias and improve predictive accuracy, ensuring consistency and reducing noise.
Explore how traditional methods fall short when applied to complex biologic formats such as bispecifics, ADCs, and other novel modalities.
Overcome cross-functional barriers between computational metrics and biological priorities to build more impactful outcomes.
Contrast the strengths of structure-based design with the speed and scalability of sequence-based approaches.
Improve predictions of biophysical & developability properties to identify truly developable candidates.